iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionFlagship Harbor Advisors, Llc
Latest Disclosed Ownership5,503 shares
Latest Disclosed Value $ 929,254
Flagship Harbor Advisors, Llc reports 40.06% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 28, 2026 - Flagship Harbor Advisors, Llc filed a 13F-HR form disclosing ownership of 5,503 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $929,254 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 3,929 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 40.06% during the quarter. The current value of the position is $721,168 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,503 1,574 40.06 929 40.12 0.0409
2026-01-21 2025-12-31 13F ISHARES BIOTECHNOLOGY MF Closed and MF Open 464287556 3,929 1,990 102.63 663 137.63 0.0313
2025-11-05 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,939 1,939 280 0.0122
2025-01-21 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 0 -2,617 -100.00 0 -100.00
2024-10-21 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,617 2,617 381 0.0209
2023-04-12 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 0 -38,086 -100.00 0 -100.00
2023-01-13 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 38,086 35,455 1,347.59 5,000 1,523.38 0.5126
2022-10-13 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,631 78 3.06 308 2.67 0.0357
2022-07-13 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,553 -365 -12.51 300 -21.05 0.0337
2022-04-13 2022-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,918 -1,372 -31.98 380 -41.98 0.0366
2022-02-17 2021-12-31 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 4,290 -140 -3.16 655 -9.66 0.0620
2022-02-10 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,290 -140 655 0.0620
2021-11-01 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,430 0 0.00 725 0.00 0.0779
2021-07-26 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,430 -1,907 -30.09 725 -24.00 0.0778
2021-05-03 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 6,337 -125 -1.93 954 -2.55 0.1083
2021-02-08 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 6,462 1,387 27.33 979 42.50 0.1214
2020-10-13 2020-09-30 13F ISHARES NASDAQ MF Closed and MF Open 464287556 5,075 1,509 42.32 687 41.07 0.0928
2020-07-31 2020-06-30 13F ISHARES NASDAQ MF Closed and MF Open 464287556 3,566 -60 -1.65 487 24.55 0.0715
2020-05-12 2020-03-31 13F ISHARES NASDAQ MF Closed and MF Open 464287556 3,626 -146 -3.87 391 -14.07 0.0782
2020-02-14 2019-12-31 13F ISHARES NASDAQ MF Closed and MF Open 464287556 3,772 3,246 617.11 455 775.00 0.0797
2019-10-22 2019-09-30 13F ISHARES NASDAQ MF Closed and MF Open 464287556 526 -669 -55.98 52 -60.00 0.0102
2019-07-22 2019-06-30 13F ISHARES NASDAQ MF Closed and MF Open 464287556 1,195 -6,219 -83.88 130 -84.30 0.0270
2019-04-15 2019-03-31 13F ISHARES NASDAQ MF Closed and MF Open 464287556 7,414 -45 -0.60 828 15.16 0.1701
2019-01-26 2018-12-31 13F ISHARES NASDAQ ETF 464287556 7,459 -710 -8.69 719 -27.37 0.1747
2018-11-05 2018-09-30 13F ISHARES NASDAQ MF Closed and MF Open 464287556 8,169 968 13.44 990 25.32 0.1836
2018-08-14 2018-06-30 13F ISHARES NASDAQ ETF 464287556 7,201 132 1.87 790 8.82 0.1581
2018-04-23 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 7,069 449 6.78 726 1.40 0.2158
2018-01-24 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 6,620 4,477 208.91 716 -1.38 0.2058
2017-10-23 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,143 274 14.66 726 25.17 0.2355
2017-08-09 2017-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,869 154 8.98 580 18.13 0.2014
2017-05-16 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,715 206 13.65 491 19.46 0.1876
2017-05-15 2016-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,509 1,509 411 0.1774
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.